72 participants
A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2012-05-11
- Start Date:
- 2005-03-31
- Completion:
- 2010-05-31
Conditions
- Metastatic Breast Cancer
Interventions
- DRUG
No Results Yet